There are also patients that are very mildly positive for Cushings Disease where treatment may be overkill, and of course patients with owners that have
serious budgetary concerns that make treatment with trilostane cost prohibitive.
Haynie, in his statement, said that Syverud has publicly stated that SU «has grave policy
concerns» about the tax overhaul and could result in «
serious budgetary impacts for the university.»